Monash IVF chief executive Michael Knaap has quit after the embattled fertility company this week admitted to its second embryo mix-up in just three months.
The company told investors on Thursday that the board had accepted Knaap’s resignation and appointed chief financial officer and company secretary Malik Jainudeen as acting CEO.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.